Trial · NCT05805683
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
NCT05805683, Not applicable, Recruiting, Tanta University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury. Trials, record NCT05805683. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05805683
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
- NCT number
- NCT05805683
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 126 participants, estimated
- Lead sponsor
- Tanta University
- Conditions
- Calcitonin, Neuropathic Pain, Spinal Cord Injury
- Interventions
- Calcitonin, Placebo
- First posted
- 2023-04-10
- Last updated
- 2026-05-14
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intensity of neuropathic pain | 6 months after spinal cord injury | Intensity of neuropathic pain will be evaluated by visual analogue scale (VAS) scores at 6 months after spinal cord injury |
| Primary | Incidence of neuropathic pain | 6 months after spinal cord injury | Incidence of neuropathic pain at 6 months after spinal cord injury |
| Secondary | Incidence of neuropathic pain | 12 months after spinal cord injury | Incidence of neuropathic pain at 1, 3, 9 and 12 months after spinal cord injury |
| Secondary | The incidence of adverse reactions | 2 weeks after spinal cord injury | Nausea, vomiting, disturbance of serum Calcium, Magnesium and Phosphorus levels |
| Secondary | The consumption of medications for neuropathic pain or musculoskeletal pain | 12 months after spinal cord injury | Number of patients required medications for neuropathic pain or musculoskeletal pain |
| Secondary | Intensity of neuropathic pain | 12 months after spinal cord injury | Intensity of neuropathic pain will be evaluated by the visual analogue scale (VAS) score which ranges from 0 = no pain to 10= worst pain at 12 months after spinal cord injury |
| Secondary | Intensity of nociceptive pain | 12 months after spinal cord injury | Intensity of musculoskeletal pain will be evaluated by visual analogue scale (VAS) score which ranges from 0 = no pain to 10= worst pain at 1, 3, 6, 9 and 12 months after spinal cord injury |
| Secondary | Medications used for neuropathic pain management | 12 months after spinal cord injury | The number of medications used for treating neuropathic pain will be recorded |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05805683
GET https://conductscience.org/api/trials/v1/NCT05805683/registered